None specified — Drug Target

All drugs that target None specified — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Anti-angiogenic agent, Corticosteroid, Proteasome inhibitor

Phase 3 pipeline (1)

• Thalidomide/Prednisone/Velcade · PETHEMA Foundation · Anti-angiogenic agent, Corticosteroid, Proteasome inhibitor · Oncology
  Thalidomide inhibits angiogenesis and immunomodulation, while Prednisone is a corticosteroid with anti-inflammatory effects, and Velcade (Bortezomib) is a proteasome inhibitor.